Showing 214 results

Filters Content type: News, Editors' picks, About HIV Topic: People with limited treatment options

HIV treatment for people who have a strain of HIV that is resistant to multiple drug classes or who cannot take other HIV medications.

New & experimental HIV treatments

HIV attachment inhibitor BMS-663068 matches atazanavir in phase 2b study

News
14 October 2015
Pregnancy and vertical transmission

Raltegravir appears to prevent mother-to-child HIV transmission during late pregnancy

News
28 July 2015
Resistance

Exploring possible treatment options after virological failure with raltegravir

Editor's pick
CATIE
21 January 2015
The search for a cure

British HIV cure survey: most respondents would be prepared to take some health risk to help find a cure for HIV

News
28 November 2014
Treatment outcomes & life expectancy

Higher pill burden is associated with poorer adherence to HIV therapy and reduced chances of achieving an undetectable viral load

News
31 January 2014
Resistance

Janssen to Stop Offering "Virtual Phenotype" Testing, and Musings on Progress

Editor's pick
The BodyPRO
27 November 2013
Finance & funding

Second- and Third-Line ART Cost 24% and 41% More Than First Line in US

Editor's pick
NATAP
17 September 2013
People with limited treatment options

No Dose Adjustment With Etravirine Plus ATV/r in Treatment Experienced: Randomized Trial

Editor's pick
NATAP
22 July 2013
Access to healthcare

Third-line ARVs could widen treatment gap in Zimbabwe

Editor's pick
IRIN Plus News
12 March 2013
People with limited treatment options

New integrase inhibitor dolutegravir helps treatment-experienced people on failing therapy

News
10 March 2013
New & experimental HIV treatments

Can people with resistant HIV omit NRTIs when switching from a failing regimen?

News
7 March 2013
Resistance

Prevalence of drug-resistant HIV has fallen dramatically among antiretroviral-experienced patients in Western Europe

News
22 January 2013
Treatment outcomes & life expectancy

Australian researchers project that many HIV-positive people will run out of treatment options

News
22 January 2013
People with limited treatment options

Any reduction in viral load has immunologic benefits for people with HIV who have triple-class treatment failure

News
8 January 2013
People with limited treatment options

Redefining Expanded Access Programs for patients with MDR-HIV

Editor's pick
GMHC Treatment Issues
4 December 2012
Changing treatment

Raltegravir-resistant HIV stays susceptible to dolutegravir in lab

Editor's pick
International AIDS Society
13 November 2012
Generic medicines

The generic generation

News
22 October 2012
Resistance

Mutation breaks HIV's resistance to drugs

Editor's pick
Science Daily
14 September 2012
People with limited treatment options

Booster HIV Drug Can Be Dropped

Editor's pick
MedPage Today
13 September 2012
Diabetes

Glucose metabolism worsens in HIV treatment-experienced taking NRTI-sparing regimens

News
24 August 2012
People with limited treatment options

Once-daily elvitegravir works as well as raltegravir at 96 weeks

News
31 July 2012
New & experimental HIV treatments

ViiV Announces Expanded Access to Once-a-Day Integrase Inhibitor ... But Activists Are Concerned About Its Potential Misuse

Editor's pick
The Body
9 March 2012
New & experimental HIV treatments

EACS: Does Maraviroc Intensification Promote Better CD4 Cell Recovery?

Editor's pick
HIVandhepatitis.com
27 October 2011
People with limited treatment options

HIV Drug Resistance Effect Damped Down over Time

Editor's pick
MedPage Today
10 October 2011